iifl-logo

Orchid Pharma Ltd Share Price

798.6
(2.01%)
Apr 2, 2025|01:19:56 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open784.1
  • Day's High802.05
  • 52 Wk High1,997.4
  • Prev. Close782.9
  • Day's Low760
  • 52 Wk Low 761.1
  • Turnover (lac)356.99
  • P/E35.53
  • Face Value10
  • Book Value242.19
  • EPS22.05
  • Mkt. Cap (Cr.)4,050.43
  • Div. Yield0
View All Historical Data
No Records Found

Orchid Pharma Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

784.1

Prev. Close

782.9

Turnover(Lac.)

356.99

Day's High

802.05

Day's Low

760

52 Week's High

1,997.4

52 Week's Low

761.1

Book Value

242.19

Face Value

10

Mkt Cap (₹ Cr.)

4,050.43

P/E

35.53

EPS

22.05

Divi. Yield

0

Orchid Pharma Ltd Corporate Action

17 Jul 2024

12:00 AM

AGM

Announcement Date: 17 Jul, 2024

arrow

13 Jul 2023

12:00 AM

BookCloser

arrow

6 Feb 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Orchid Pharma Ltd NEWS AND UPDATE

Orchid Pharma Clears USFDA Inspection, Secures EU GMP Renewal
20 Feb 2025|03:36 PM

The inspection raised, seven minor observations none related to data integrity, and therefore, the facility remains compliant under stringent regulatory standards.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Orchid Pharma Ltd SHAREHOLDING SNAPSHOT

02 Apr, 2025|01:50 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 69.83%

Foreign: 0.00%

Indian: 69.83%

Non-Promoter- 21.53%

Institutions: 21.52%

Non-Institutions: 8.64%

Custodian: 0.00%

Share Price

Orchid Pharma Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

119.28

109.38

109.38

109.38

Preference Capital

0

0

0

0

Reserves

1,099.04

622.59

568.58

571.96

Net Worth

1,218.32

731.97

677.96

681.34

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

556.97

450.69

505.44

644.16

yoy growth (%)

23.58

-10.83

-21.53

-14.71

Raw materials

-314.07

-229.27

-240.23

-330.86

As % of sales

56.38

50.87

47.52

51.36

Employee costs

-60.2

-64.39

-81.48

-82.39

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

-52.77

-95.87

-149.83

-401.47

Depreciation

-87.02

-108.89

-125.9

-133.29

Tax paid

0

0

0

46.19

Working capital

-202.58

-42.4

475.45

-144.74

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

23.58

-10.83

-21.53

-14.71

Op profit growth

-1.1

-230.8

-425.39

-703.41

EBIT growth

-53.38

-69.42

45.93

-12.7

Net profit growth

-95.89

-21.81

-57.82

-27.27

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

819.37

665.9

559.56

450.06

483.81

Excise Duty

0

0

0

0

0

Net Sales

819.37

665.9

559.56

450.06

483.81

Other Operating Income

0

0

0

0

0

Other Income

30.86

58.64

67.47

15.23

24.28

Orchid Pharma Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,698.35

129.244,07,155.151,181.050.85,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,549.7

71.051,47,295.245940.542,297513.62

Cipla Ltd

CIPLA

1,444.25

25.071,16,664.331,438.150.94,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,183.9

59.031,07,673.274850.882,330222.38

Mankind Pharma Ltd

MANKIND

2,458.1

52.421,01,358.17416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Orchid Pharma Ltd

Management

Register Office

Registrar Office

Independent Director

Tanu Singla

Independent Director

Manoj Goyal

Managing Director

Manish Dhanuka

Whole-time Director

Mridul Dhanuka

Chairman (Non-Executive)

Ram Gopal Agarwal

Non Executive Director

Arjun Dhanuka

Independent Director

Dharam Vir

Independent Director

Shubha Singh

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Orchid Pharma Limited, is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals with exports spanning over 40 countries. Orchids world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India. The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company has a portfolio of antibiotics, and veterinary products. Antibiotics are life-saving drugs used to ght infections. Different classes of antibiotics include Beta-lactam, Macrolide, Fluoroquinolone, Imidazoleetc. Cephalosporins are beta-lactam antimicrobials used to manage various infections from gram-positive and gramnegative bacteria. The ve generations of cephalosporins are useful against skin infections, urinary tract infections, lower respiratory tract infections, sexually transmitted diseases, surgical prophylaxis, and other infections like meningitis. Company is also engaged in manufacturing and export of general category nished dosage formulations and anti-infective nished dosage formulations through its formulation facilities.The Company is a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms
Read More

Company FAQs

What is the Orchid Pharma Ltd share price today?

The Orchid Pharma Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹798.6 today.

What is the Market Cap of Orchid Pharma Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Orchid Pharma Ltd is ₹4050.43 Cr. as of 02 Apr ‘25

What is the PE and PB ratio of Orchid Pharma Ltd?

The PE and PB ratios of Orchid Pharma Ltd is 35.53 and 3.13 as of 02 Apr ‘25

What is the 52 Week High and Low of Orchid Pharma Ltd?

The 52-week high/low is the highest and lowest price at which a Orchid Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Orchid Pharma Ltd is ₹761.1 and ₹1997.4 as of 02 Apr ‘25

What is the CAGR of Orchid Pharma Ltd?

Orchid Pharma Ltd's CAGR for 5 Years at 112.66%, 3 Years at 37.76%, 1 Year at -29.24%, 6 Month at -41.34%, 3 Month at -57.35% and 1 Month at -15.02%.

What is the shareholding pattern of Orchid Pharma Ltd?

The shareholding pattern of Orchid Pharma Ltd is as follows:
Promoters - 69.84 %
Institutions - 21.52 %
Public - 8.64 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.